YKL-40 protein in osteosarcoma tumor tissue

Area of Science:

• Oncology
• Biochemistry
• Immunohistochemistry

Background:

• YKL-40 is a glycoprotein found in elevated blood levels in cancer patients, acting as a prognostic survival variable.
• Tissue expression of YKL-40 in cancer shows variable results, with conflicting survival data in some cancer types.
• Osteosarcoma (OS) is a primary bone cancer where YKL-40's role as a predictive marker requires further investigation.

Purpose of the Study:

• To examine the tissue expression of YKL-40 in osteosarcoma (OS) patients.
• To determine if YKL-40 expression can serve as a predictive marker for survival in OS.
• To correlate YKL-40 expression levels with patient survival data.

Main Methods:

• Immunohistochemistry was used to analyze YKL-40 expression in diagnostic biopsies from 48 OS patients.
• YKL-40 staining scores were determined based on the tumor cell/stroma ratio.
• Survival data were statistically analyzed in relation to YKL-40 staining scores.

Main Results:

• Intense YKL-40 immunostaining was universally observed in all osteosarcoma tumor cells.
• A significant correlation was found between a high YKL-40 tumor cell/stroma ratio and better patient survival (p = 0.05).
• YKL-40 expression in tumor cells, not macrophages, was linked to improved overall survival in OS.

Conclusions:

• High YKL-40 expression in tumor cells is associated with longer overall survival in osteosarcoma patients.
• YKL-40 may function as a predictive biomarker for improved prognosis in osteosarcoma.
• These findings contrast with some previous studies, highlighting the specific role of YKL-40 in OS tumor microenvironment.